MAPT and Alzheimer disease: Alzheimer's disease (AD), as the most prevalent neurodegenerative disorder among the global elderly population, manifests neuropathological features encompassing tau protein entanglements, β‐amyloid (Aβ) plaques, as well as the loss and impairment of neurons and synapses.